Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum
SYDNEY, June 21, 2022 (GLOBE NEWSWIRE) — Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused […]
